IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q3 2023 Holdings

Filed 2023-11-14 | 3 holdings | $103.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$56.4M2,346,93454.7%
Lyell Immunopharma IncCOM55083R104$29.6M20,162,33228.7%
Prime Medicine Inc(PRME)COM74168J101$17.1M1,792,21016.6%